Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Binge-Eating Disorder

NCT00402584 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00402584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00402584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Examine the Efficacy and Safety of Meridia (Sibutramine Hydrochloride) in Binge-Eating Disorder
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2000
Completion date
Not reported
Enrollment
304 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder, obesity